IRADIMED CORPORATION (IRMD)
NASDAQ: IRMD · Real-Time Price · USD
49.27
-3.67 (-6.93%)
At close: Oct 31, 2024, 4:00 PM
49.99
+0.72 (1.46%)
After-hours: Oct 31, 2024, 4:02 PM EDT
IRADIMED CORPORATION Revenue
IRADIMED CORPORATION had revenue of $17.93M in the quarter ending June 30, 2024, with 11.15% growth. This brings the company's revenue in the last twelve months to $69.48M, up 16.05% year-over-year. In the year 2023, IRADIMED CORPORATION had annual revenue of $65.56M with 23.00% growth.
Revenue (ttm)
$69.48M
Revenue Growth
+16.05%
P/S Ratio
8.74
Revenue / Employee
$481,791
Employees
148
Market Cap
624.24M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 65.56M | 12.26M | 23.00% |
| Dec 31, 2022 | 53.30M | 11.49M | 27.48% |
| Dec 31, 2021 | 41.81M | 10.10M | 31.83% |
| Dec 31, 2020 | 31.72M | -6.80M | -17.65% |
| Dec 31, 2019 | 38.52M | 8.08M | 26.54% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ironwood Pharmaceuticals | 400.57M |
| Y-mAbs Therapeutics | 86.55M |
| EyePoint Pharmaceuticals | 50.39M |
| Stoke Therapeutics | 15.16M |
| ABIVAX Société Anonyme | 9.68M |
| Lexicon Pharmaceuticals | 3.64M |
| Mereo BioPharma Group | 1.00M |
IRMD News
- 12 hours ago - IRADIMED CORPORATION Announces Third Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share - GlobeNewsWire
- 7 days ago - IRADIMED CORPORATION to Hold 2024 Third Quarter Financial Results Conference Call on October 31st - GlobeNewsWire
- 4 weeks ago - IRADIMED CORPORATION to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - GlobeNewsWire
- 7 weeks ago - IRADIMED CORPORATION To Participate in the Lake St. Annual Best Ideas Growth “Big 8” Investor Conference - GlobeNewsWire
- 3 months ago - IRADIMED CORPORATION (IRMD) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - IRADIMED CORPORATION Announces Second Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share - GlobeNewsWire
- 3 months ago - IRADIMED CORPORATION to Hold 2024 Second Quarter Financial Results Conference Call on August 1st - GlobeNewsWire
- 5 months ago - IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market - GlobeNewsWire